|
EED expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.306100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.301650E-01 |
| Normal-vs-Stage2 |
1.312230E-01 |
| Normal-vs-Stage3 |
3.362600E-01 |
| Normal-vs-Stage4 |
2.433800E-02 |
| Stage1-vs-Stage2 |
5.540200E-01 |
| Stage1-vs-Stage3 |
5.465200E-01 |
| Stage1-vs-Stage4 |
1.723570E-01 |
| Stage2-vs-Stage3 |
3.665200E-01 |
| Stage2-vs-Stage4 |
6.210800E-01 |
| Stage3-vs-Stage4 |
9.749900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.040840E-01 |
| Normal-vs-AfricanAmerican |
1.304250E-01 |
| Normal-vs-Asian |
3.748500E-02 |
| Caucasian-vs-AfricanAmerican |
8.925000E-01 |
| Caucasian-vs-Asian |
1.932390E-01 |
| AfricanAmerican-vs-Asian |
1.275820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.104300E-02 |
| Normal-vs-Female |
4.642400E-02 |
| Male-vs-Female |
6.015800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.565640E-01 |
| Normal-vs-Age(41-60Yrs) |
3.184200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.144000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.201000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.961600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.200200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.969170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.583800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.296040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.284200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.956400E-02 |
| Normal-vs-Grade 2 |
8.943700E-02 |
| Normal-vs-Grade 3 |
3.116800E-01 |
| Normal-vs-Grade 4 |
3.019800E-02 |
| Grade 1-vs-Grade 2 |
4.527400E-01 |
| Grade 1-vs-Grade 3 |
1.395950E-01 |
| Grade 1-vs-Grade 4 |
8.877400E-01 |
| Grade 2-vs-Grade 3 |
1.878560E-01 |
| Grade 2-vs-Grade 4 |
3.011600E-01 |
| Grade 3-vs-Grade 4 |
7.833600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.042000E-02 |
| Normal-vs-ccB subtype |
1.735200E-01 |
| ccA subtype-vs-ccB subtype |
5.149800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.433790E-01 |
| Normal-vs-N1 |
1.404180E-01 |
| N0-vs-N1 |
3.122000E-01 |
|
|
